Granahan Investment Management, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1026710
WALTHAM, MA
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,118,123
+$1,771,370 QoQ
Shares Held
898,753
-2.5% QoQ
Ownership
0.493%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#31
of 238 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Granahan Investment Management, LLC holds $16,820,936 across 2 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (42.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
151,725 | $9,702,813 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
898,753 | $7,118,123 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,118,123 | 898,753 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,346,753 | 921,854 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,603,721 | 1,223,404 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,850,367 | 350,168 | Shares | Sole | 2025-11-14 | |
| 2022-03-31 | $1,037,432 | 405,247 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,537,113 | 524,612 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||